Crosstalk between the p38 and TGF-β signaling pathways through TβRI, TβRII and Smad3 expression in plancental choriocarcinoma JEG-3 cells

Oncology Letters

Volumn 8, Issue 3, 2014, Pages 1307-1311

  Tan, Yusi ^a   Xu, Qian ^a   Li, Yuhong ^a   Mao, Xiaodan ^a   Zhang, Kongyan ^a  

^a CHENGDE MEDICAL COLLEGE   (China)

Author keywords

Choriocarcinoma; p38 MAPK; Smad3; TGF ; T RI; T RII

Indexed keywords

EID: 84904264313     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2255     Document Type: Article

References (35)

1. Alifrangis C and Seckl MJ: Genetics of gestational trophoblastic neoplasia: an update for the clinician. Future Oncol 6: 1915-1923, 2010.
2. Braunstein GD: Endocrine changes in pregnancy. In: Williams Textbook of Endocrinology. 12th edition. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds). Saunders Elsevier, Philadelphia, Pa, pp221-230, 2011.
3. Lin KW, Yakymovych I, Jia M, Yakymovych M and Souchelnytskyi S: Phosphorylation of eEF1A1 at Ser300 by TβR-I results in inhibition of mRNA translation. Curr Biol 20: 1615-1625, 2010.
4. Sawai H, Yasuda A, Ochi N, et al: TGF-β regulates invasive behavior of human pancreatic cancer cells by controlling Smad expression. Arch Med Sci 3: 185-191, 2007.
5. Bandyopadhyay B, Han A, Dai J, et al: TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression. J Cell Sci 124 (Pt 1): 19-24, 2011.
6. Huang F and Chen YG: Regulation of TGF-β receptor activity. Cell Bios 2: 9-19, 2012.
7. Calone I and Souchelnytskyi S: Inhibition of TGFβ signaling and its implications in anticancer treatments. Exp Oncol 34: 9-16, 2012.
8. Galliher-Beckley AJ and Schiemann WP: Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. Carcinogenesis 29: 244-251, 2008.
9. Jin Gao, Laurence JW and Anne L S: Potential regeneration capacity of periodontal ligament with autocrine production of transforming growth factor-beta 1 and its receptors. Int J Dent Clin 3: 5-8, 2011.
10. Shi Y and Massagué J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
11. Lu L, Wang J, Zhang F, et al: Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 84: 4295-4306, 2010.
12. Konrad L, Scheiber JA, Völck-Badouin E, et al: Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells. BMC Genomics 8: 318, 2007.
13. Shinto O, Yashiro M, Kawajiri H, Shimizu K, Shimizu T, Miwa A and Hirakawa K: Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 102: 844-851, 2010.
14. Bakkebø M, Huse K, Hilden VI, Smeland EB and Oksvold MP: TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK. BMC Immunol 11: 57, 2010.
15. Corrêa SA and Eales KL: The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduct 2012: 649079, 2012.
16. Whitmarsh AJ: A central role for p38 MAPK in the early transcriptional response to stress. BMC Biol 8: 47, 2010.
17. Wood CD, Thornton TM, Sabio G, Davis RA and Rincon M: Nuclear localization of p38 MAPK in response to DNA damage. Int J Biol Sci 5: 428-437, 2009.
18. Gangwal RP, Bhadauriya A, Damre MV, Dhoke GV and Sangamwar AT: p38 mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies. Curr Top Med Chem 13: 1015-1035, 2013.
19. Krementsov DN, Thornton TM, Teuscher C and Rincon M: The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models. Mol Cell Biol 33: 3728-3734, 2013.
20. Mavropoulos A, Orfanidou T, Liaskos C, et al: p38 MAPK signaling in pemphigus: implications for skin autoimmunity. Autoimmune Dis 2013: 728529, 2013.
21. Xu Q, Tan Y, Zhang K and Li Y: Crosstalk between p38 and Smad3 through TGF-β1 in JEG-3 choriocarcinoma cells. Int J Oncol 43: 1187-1193, 2013.
22. Mincione G, Di Marcantonio MC, Artese L, et al: Loss of expression of TGF-beta1, TbetaRI and TbetaRII correlates with differentiation in humanoral squamous cell carcinomas. Int J Oncol 32: 323-331, 2008.
23. Zhang YE: Non-Smad pathways in TGF-β signaling. Cell Res 19: 128-139, 2009.
24. Chapnick DA, Warner L, Bernet J, Rao T and Liu X: Partners in crime: TGFβ and MAPK pathways in cancer progression. Cell Biosci 1: 42, 2011.
25. Liu X, Gu W and Li X: HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation. Placenta 34: 1044-1052, 2013.
26. Bian J, Li B, Zeng X, et al: Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway. Int J Oncol 43: 1549-1559, 2013.
27. Zhang P, Nakatsukasa H, Tu E and Kasagi S: PARP-1 regulates expression of TGF-β receptors in T cells. Blood 122: 2224-2232, 2013.
28. Braunger BM, Pielmeier S, Demmer C, et al: TGF-β signaling protects retinal neurons from programmed cell death during the development of the mammalian eye. J Neurosci 33: 14246-14258, 2013.
29. Schedlich LJ, Yenson VM, Baxter RC: TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. Mol Cell Endocrinol 377: 56-64, 2013.
30. Bhowmick NA, Zent R, Ghiassi M, McDonnell M and Moses HL: Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38 MAPKand epithelial plasticity. J Biol Chem 276: 46707-46713, 2001.
31. Daroqui MC, Vazquez P, Bal de Kier Joffé E, Bakin AV and Puricelli LI: TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammaryadenocarcinoma tumor progression. Oncol Rep 28: 567-575, 2012.
32. Gui T, Sun Y, Shimokado A and Muragaki Y: The roles of mitogen-activated protein kinase pathways in TGF-β-induced epithelial-mesenchymal transition. J Signal Transduct 2012: 289243, 2012.
33. Jachec W, Foremny A, Domal-Kwiatkowska D, et al: Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Int J Mol Med 21: 99-107, 2008.
34. Galliher AJ, Schiemann WP: Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752-3758, 2007.
35. Ohshima T and Shimotohno K: Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem 278: 50833-50842, 2003.